JY
AGL icon

Jeff Yass’s Agilon Health AGL Stock Holding History

Jeff Yass’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Sell
4,600
-6,970
-60% -$457K ﹤0.01% 9955
2026
Q1 		$91.5K Sell
11,570
-4,913
-30% -$79.4K ﹤0.01% 12399
2025
Q4 		$284K Buy
16,483
+12,660
+331% +$245K ﹤0.01% 10076
2025
Q3 		$98.4K Sell
3,823
-14,727
-79% -$556K ﹤0.01% 11573
2025
Q2 		$1.07M Buy
18,550
+3,189
+21% +$256K ﹤0.01% 7246
2025
Q1 		$1.66M Sell
15,361
-367
-2% -$31.9K ﹤0.01% 5956
2024
Q4 		$747K Buy
15,728
+14,792
+1,580% +$894K ﹤0.01% 7664
2024
Q3 		$91.9K Sell
936
-31
-3% -$4K ﹤0.01% 11099
2024
Q2 		$158K Sell
967
-22,414
-96% -$3.19M ﹤0.01% 10642
2024
Q1 		$3.57M Buy
23,381
+21,674
+1,270% +$3.61M ﹤0.01% 4188
2023
Q4 		$535K Sell
1,707
-2,970
-64% -$1.07M ﹤0.01% 8500
2023
Q3 		$2.08M Buy
+4,677
New +$2.11M ﹤0.01% 5045
2023
Q2 		– Sell
-1,767
Closed -$993K – 11963
2023
Q1 		$1.05M Buy
+1,767
New +$990K ﹤0.01% 6686
2022
Q3 		– Sell
-1,242
Closed -$744K – 13079
2022
Q2 		$678K Buy
1,242
+691
+125% +$349K ﹤0.01% 7499
2022
Q1 		$349K Sell
551
-1,375
-71% -$709K ﹤0.01% 9886
2021
Q4 		$1.3M Sell
1,926
-32
-2% -$19.5K ﹤0.01% 6565
2021
Q3 		$1.28M Buy
1,958
+1,386
+242% +$1.18M ﹤0.01% 6911
2021
Q2 		$580K Buy
+572
New +$501K ﹤0.01% 9238

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jeff Yass's AGL Position: Q2 2026 in Review

Jeff Yass reduced its Agilon Health (AGL) stake by 60% in Q2 2026, selling an estimated $457K and leaving 4,600 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #9955.

Jeff Yass first reported a position in AGL in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.57M in Q1 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Jeff Yass held 4,600 shares of Agilon Health worth $493K as of Q2 2026.
  • Jeff Yass sold 6,970 Agilon Health shares in Q2 2026, an estimated $457K.
  • Agilon Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9955 holding.
  • Jeff Yass first reported a position in Agilon Health in Q2 2021 and has held it in 18 quarters since.
  • Jeff Yass's Agilon Health position peaked at $3.57M in Q1 2024.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.